Forte Biosciences, Inc. (FBRX)
76.99
0.00 (0.00%)
USD |
NASDAQ |
Oct 02, 16:00
Forte Biosciences Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2019 | -189.8K% |
| December 31, 2018 | -217.8K% |
| September 30, 2018 | -2.13% |
| June 30, 2018 | -178.8K% |
| March 31, 2018 | -143.1K% |
| December 31, 2017 | -108.4K% |
| Date | Value |
|---|---|
| September 30, 2017 | -99.53K% |
| June 30, 2017 | -90.66K% |
| March 31, 2017 | -82.48K% |
| June 30, 2016 | -61.86K% |
| March 31, 2016 | -57.19K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| argenx SE | -- |
| ACADIA Pharmaceuticals, Inc. | 10.23% |
| Alnylam Pharmaceuticals, Inc. | 12.74% |
| Savara, Inc. | -- |
| Vericel Corp. | 2.85% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -93.63% |
| Return on Assets | -78.43% |
| Return on Invested Capital | -93.63% |
| Return on Net Operating Assets | -3.08K% |